These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 17933205)
21. Does your pharmacy have a compounding isolator? LaBella CJ Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203 [No Abstract] [Full Text] [Related]
23. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores. Katayama H; Toda A; Tokunaga Y; Katoh S PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952 [TBL] [Abstract][Full Text] [Related]
24. CFD modeling of pharmaceutical isolators with experimental verification of airflow. Nayan N; Akay HU; Walsh MR; Bell WV; Troyer GL; Dukes RE; Mohan P PDA J Pharm Sci Technol; 2007; 61(4):237-54. PubMed ID: 17933207 [TBL] [Abstract][Full Text] [Related]
25. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes. Krämer I; Federici M; Kaiser V; Thiesen J J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919 [TBL] [Abstract][Full Text] [Related]
27. Methodologies for quantifying culturable, viable, and total Legionella pneumophila in indoor air. Chang CW; Chou FC Indoor Air; 2011 Aug; 21(4):291-9. PubMed ID: 21198889 [TBL] [Abstract][Full Text] [Related]
28. Examination of the order of incubation for the recovery of bacteria and fungi from pharmaceutical-grade cleanrooms. Sandle T Int J Pharm Compd; 2014; 18(3):242-7. PubMed ID: 25306772 [TBL] [Abstract][Full Text] [Related]
29. Fungal contamination and air sampling. Fritz PM; Recer GM Ann Allergy Asthma Immunol; 2003 Oct; 91(4):419; author reply 419-20. PubMed ID: 14582825 [No Abstract] [Full Text] [Related]
30. Influence of background air on microbial contamination during simulated i.v.-admixture preparation. van Doorne H; Bakker JH; Meevis RF; Marskamp A J Clin Pharm Ther; 1994 Jun; 19(3):181-7. PubMed ID: 7962221 [TBL] [Abstract][Full Text] [Related]
31. [Hospitals location and indoor air microbiological quality]. Krogulski A Rocz Panstw Zakl Hig; 2008; 59(1):97-102. PubMed ID: 18666627 [TBL] [Abstract][Full Text] [Related]
32. Environmental air pollution in an intensive care unit for nephrology and dialysis. Buemi M; Floccari F; Nettò M; Allegra A; Grasso F; Mondio G; Perillo P J Nephrol; 2000; 13(6):433-6. PubMed ID: 11132759 [TBL] [Abstract][Full Text] [Related]
33. Choosing a Vial Processing Line for Aseptic Compounding: Part 1. Noorian S; Vahedi N Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673 [TBL] [Abstract][Full Text] [Related]
34. Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study. Ziegler I; Borbély-Jakab J; Sugó L; Kovács RJ PDA J Pharm Sci Technol; 2017; 71(3):234-244. PubMed ID: 28089966 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of microbial contamination of air in two haematology departments equipped with ventilation systems with different filtration devices. Crimi P; Valgiusti M; Macrina G; Grieco A; Massone L; Ciucci A; Ansaldi F; Sticchi L; Sasso L; Del Buono S; Durando P J Prev Med Hyg; 2009 Mar; 50(1):33-6. PubMed ID: 19771758 [TBL] [Abstract][Full Text] [Related]
36. [Fungal contamination of dwelling and public buildings: hygienic aspects]. Gubernskiĭ IuD; Nel'nikova AI; Kalinina NV; Chuprina OV Gig Sanit; 2010; (5):26-8. PubMed ID: 21344696 [TBL] [Abstract][Full Text] [Related]
37. Establishment of critical contamination risk locations ("hot spots") in environmental monitoring by means of three-dimensional airflow analysis and particulate evaluation. Katayama H; Higo T; Tokunaga Y; Hiyama Y; Morikawa K PDA J Pharm Sci Technol; 2005; 59(1):49-63. PubMed ID: 15796135 [TBL] [Abstract][Full Text] [Related]